innerBanner.jpg

FUE Central Library

Image from Google Jackets

Pharmaceutical product licensing : requirements for Europe / editors, A.C. Cartwright and Brian R. Matthews.

Contributor(s): Material type: TextTextSeries: Ellis Horwood series in pharmaceutical technologyPublisher: New York : Ellis Horwood, 1991Description: 328 pages ; illustrations : 23 cmContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781134994908
Uniform titles:
  • SCI-TECHnetBASE.
Subject(s): Additional physical formats: Print version:: No titleDDC classification:
  • 341.754756151 P 23
LOC classification:
  • KJE6191 .P43 1991
Online resources:
Contents:
PREFACE, 1. INTRODUCTION AND HISTORY OF PHARMACEUTICAL REGULATION, 2. THE EUROPEAN COMMUNITY: ITS STRUCTURE, INSTITUTIONS, AND REGULATION, 3. NEW CHEMICAL ACTIVE SUBSTANCE PRODUCTS: QUALITY REQUIREMENTS, 4. NEW CHEMICAL ACTIVE SUBST ANCE PRODUCTS: PRECLINICAL REQUIREMENTS, 5. NEW CHEMICAL ACTIVE SUBSTANCE PRODUCTS: CLINICAL REQUIREMENTS, 6. ABRIDGED APPLICATIONS, 7. DRUG MASTER FILES, 8. RADIOPHARMACEUTICAL PRODUCTS, 9. MEDICATED DEVICES, 10. CONTACT LENS PRODUCTS AND INTRAUTERINE CONTRACEPTIVE DEVICES, 11. EXPERTS AND EXPERT REPORTS IN MARKETING AUTHORISATION APPLICATIONS, 12. DEFECTS IN APPLICATIONS -AN ANALYSIS, 13. CPMP AND THE PHARMACEUTICAL COMMITTEE, 14. CPMP MULTISTATE PROCEDURE, 15. THE CONCERTATION (HIGH TECHNOLOGYIBIOTECHNOLOGY) PROCEDURE, 16. REGULATORY STRATEGY: THE EC, EFTA, THE PER SCHEME, 17. THE UNITED KINGDOM'S SYSTEM FOR LICENSING PHARMACEUTICAL PRODUCTS, 18. THE OTHER NATIONAL AUTHORITIES IN THE EC, 19. EEC GUIDELINES -QUALITY, SAFETY, EFFICACY, AND BIOTECHNOLOGY, 20. THE NEW GENERAL DIRECTIVE, IMMUNOLOGICALS, ETC. DIRECTIVES, 21. THE SINGLE MARKET AFTER 1992: NEW DIRECTIONS, APPENDIX: ABBREVIATIONS AND ACRONYMS, INDEX
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)

PREFACE, 1. INTRODUCTION AND HISTORY OF PHARMACEUTICAL REGULATION, 2. THE EUROPEAN COMMUNITY: ITS STRUCTURE, INSTITUTIONS, AND REGULATION, 3. NEW CHEMICAL ACTIVE SUBSTANCE PRODUCTS: QUALITY REQUIREMENTS, 4. NEW CHEMICAL ACTIVE SUBST ANCE PRODUCTS: PRECLINICAL REQUIREMENTS, 5. NEW CHEMICAL ACTIVE SUBSTANCE PRODUCTS: CLINICAL REQUIREMENTS, 6. ABRIDGED APPLICATIONS, 7. DRUG MASTER FILES, 8. RADIOPHARMACEUTICAL PRODUCTS, 9. MEDICATED DEVICES, 10. CONTACT LENS PRODUCTS AND INTRAUTERINE CONTRACEPTIVE DEVICES, 11. EXPERTS AND EXPERT REPORTS IN MARKETING AUTHORISATION APPLICATIONS, 12. DEFECTS IN APPLICATIONS -AN ANALYSIS, 13. CPMP AND THE PHARMACEUTICAL COMMITTEE, 14. CPMP MULTISTATE PROCEDURE, 15. THE CONCERTATION (HIGH TECHNOLOGYIBIOTECHNOLOGY) PROCEDURE, 16. REGULATORY STRATEGY: THE EC, EFTA, THE PER SCHEME, 17. THE UNITED KINGDOM'S SYSTEM FOR LICENSING PHARMACEUTICAL PRODUCTS, 18. THE OTHER NATIONAL AUTHORITIES IN THE EC, 19. EEC GUIDELINES -QUALITY, SAFETY, EFFICACY, AND BIOTECHNOLOGY, 20. THE NEW GENERAL DIRECTIVE, IMMUNOLOGICALS, ETC. DIRECTIVES, 21. THE SINGLE MARKET AFTER 1992: NEW DIRECTIONS, APPENDIX: ABBREVIATIONS AND ACRONYMS, INDEX

There are no comments on this title.

to post a comment.

Copyright © 2023, Future University Egypt. All rights reserved.